医药市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00029839
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

预计 2023 年至 2031 年期间医药市场的复合年增长率为 12.50%,市场规模将从 2023 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

报告根据产品(小分子、生物和生物仿制药、疫苗、其他)进行了分析。报告按适应症(抗病毒、抗感染、肿瘤、呼吸系统疾病、心血管疾病、神经系统疾病、其他)进行细分。报告还根据类型(处方药、非处方药)和分销渠道(医院药房、零售药房、网上药房)进行了分析。全球分析进一步细分为区域和主要国家。范围涵盖所有关键细分市场的全球、区域和国家层面的市场规模和预测。报告以美元为单位提供了上述分析和细分的价值。报告提供了主要市场参与者的市场状况的关键统计数据,并提供了市场趋势和机会。

报告目的

Insight Partners 的《医药市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种商业利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

医药市场细分

 

产品

  • 小分子
  • 生物制品和生物仿制药
  • 疫苗
  • 其他的

指征

  • 抗病毒物质
  • 抗感染
  • 肿瘤学
  • 呼吸系统疾病
  • 心血管疾病
  • 神经系统疾病
  • 其他的

类型

  • 处方药
  • 非处方药

分销渠道

  • 医院药房
  • 零售药店
  • 网上药店

分销渠道

  • 医院药房
  • 零售药店
  • 网上药店

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

医药市场:战略洞察

Pharmaceutical Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

医药市场增长动力

  • 生物制剂和 mRNA 技术的演变:新型生物制剂和 mRNA 技术为制药业带来了巨大变革。因此,靶向治疗和疫苗的快速生产得到了很好的促进,例如 COVID-19 疫苗。这些将进一步提高治疗效果;因此,随着公司投资这些技术,发展潜力驱动市场增长,治疗选择更加广泛。
  • 个性化医疗革命:个性化医疗正在填补医药市场的空白。这是基因组学和生物技术的进步,为基于个体患者基因型的药物治疗铺平了道路。这实际上意味着这种特定的治疗方法可以带来更好的治疗效果,并提高针对某些疾病的创新解决方案的性能,从而进一步推动市场的发展。
  • 慢性病用药发展趋势:慢性病呈上升趋势,因此慢性病用药量增长,有助于改善此类疾病的控制。因此,制药公司的投资转向旨在建立糖尿病管理或心血管疾病管理等靶向治疗的研究,从而扩大其创新和市场产品。

医药市场未来趋势

  • 分散式临床试验增加:随着时间的推移,分散式临床试验 (DCT) 正在为患者带来便利和参与。DCT 将为患者开展高效且极具吸引力的试验,通过使用数字工具以及远程监控和收集数据来收集真实世界的数据。
  • 制药业可持续发展计划:在制药行业,可持续发展成为制药商日益关注的主题。环保做法通常转向使用限制公司影响的设备和不同工艺。这是更大的企业社会责任承诺的一部分,旨在吸引有环保意识的消费者和利益相关者。
  • 数字疗法发展迅猛:数字疗法似乎是医药市场的一个新兴趋势。这些经过实证检验的软件应用程序通过移动应用程序或设备提供治疗干预,因为人们可以使用手机来管理慢性疾病。因此,将数字疗法与治疗方案相结合,患者-用户将能够提高参与度和依从性。

医药市场机会

  • 向新兴市场扩张:制药公司瞄准新兴市场是因为医疗保健需求不断增长,基础设施不断改善。随着可支配收入的增长,对平价药品的需求也越来越大。这一趋势为公司提供了扩大业务范围的机会,同时满足了这些地区尚未满足的医疗需求。
  • 投资利基疗法的研发:制造商可以通过投资罕见病或个性化治疗类别的利基疗法的研发来获得收益或利润。公司确实可以通过专注于服务不足的市场来脱颖而出,并满足患者的重要需求,从而实现增长。
  • 利用真实世界证据:真实世界证据 (RWE) 是指从经验中收集有关治疗在推出后有效性和安全性的证据。制药行业可以通过将 RWE 纳入临床开发来帮助制定战略,这可能导致监管提交和营销活动,包括向多个利益相关者展示产品价值。

 

医药市场区域洞察

Insight Partners 的分析师已详细解释了预测期内影响医药市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的医药市场细分和地理位置。

Pharmaceutical Market
  • 获取医药市场的区域特定数据

医药市场报告范围

报告属性细节
2023 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2023 - 2031)12.50%
史料2021-2022
预测期2024-2031
涵盖的领域按产品
  • 小分子
  • 生物制品和生物仿制药
  • 疫苗
  • 其他的
按适应症
  • 抗病毒物质
  • 抗感染
  • 肿瘤学
  • 呼吸系统疾病
  • 心血管疾病
  • 神经系统疾病
  • 其他的
按类型
  • 处方药
  • 非处方药
按分销渠道
  • 医院药房
  • 零售药店
  • 网上药店
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 强生公司
  • 辉瑞公司
  • 默克公司
  • 雅培实验室
  • 安进公司
  • 礼来公司
  • 百时美施贵宝公司
  • 新基公司
  • 夏尔公司

 

医药市场参与者密度:了解其对业务动态的影响

医药市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在医药市场运营的主要公司有:

  1. 强生公司
  2. 辉瑞公司
  3. 默克公司
  4. 雅培实验室
  5. 安进公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Pharmaceutical Market

 

  • 了解医药市场顶级关键参与者概况

 

 

主要卖点

 

  • 全面覆盖:报告全面涵盖了医药市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,医药市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the pharmaceutical market?

The pharmaceutical market is estimated to grow with a CAGR of 7.2% from 2023 to 2031

Which region is expected to witness fastest growth rate by 2031?

Asia Pacific region is likely to witness fastest growth rate during the forecast period

Which are the leading players operating in the pharmaceutical market?

The cosmetic surgery majorly consists of the players such as Galderma, Merz Pharma, Allergan Plc. among others.

What are the driving factors impacting the pharmaceutical market?

The market drivers include rising disposable income and increasing aging population are driving the pharmaceutical market

What are the future trends of the pharmaceutical market?

Personalized aesthetic surgeries likely to remain the key trend during the forecast period

Which region dominated the pharmaceutical market in 2023?

North America dominated the pharmaceutical market in 2023

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

  • Johnson & Johnson
  • Pfizer Inc.
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Amgen Inc.
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Shire plc
  • Zoetis Inc.

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.